Cancer Research Cancer Research Funding Available  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kinoshita, Y.
Right arrow Articles by Chen, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kinoshita, Y.
Right arrow Articles by Chen, S.
[Cancer Research 63, 3546-3555, July 1, 2003]
© 2003 American Association for Cancer Research


Endocrinology

Induction of Aromatase (CYP19) Expression in Breast Cancer Cells through a Nongenomic Action of Estrogen Receptor {alpha}1

Yoshiyuki Kinoshita and Shiuan Chen2

Department of Surgical Research, Beckman Research Institute of the City of Hope, Duarte, California 91010

Aromatase plays a critical role in breast cancer development by converting androgen to estrogen. In this report, results are presented to demonstrate that estrogen, the product of aromatase, can up-regulate its expression. Estrogen receptor (ER) transient transfection experiments were performed using the SK-BR-3 breast cancer cell line, which is ER negative and expresses aromatase. When SK-BR-3 cells were transfected with the expression plasmid pCI-ER{alpha}, but not pCI-ERß, aromatase activity was elevated by 17ß-estradiol (E2) in a dose-dependent manner. The E2 induction could be enhanced by cotransfection with the coactivator GRIP1 and suppressed by antiestrogens such as tamoxifen and ICI 182,780. The aromatase activity in the ER{alpha}-transfected SK-BR-3 cells could also be induced by environmental chemicals that were known to have an estrogen-like activity. Using aromatase gene exon Is-specific reverse transcription-PCR, the level of promoter I.1-driven transcripts was found to be elevated in E2-treated ER{alpha}-transfected cells. This suggested that E2 induced aromatase expression through the up-regulation of promoter I.1. Using DNA deletion analysis of the 5'-flanking region of promoter I.1, the section between -300 and -280 bp upstream from exon I.1 was identified to be important for mediating E2 induction. However, a direct binding of ER{alpha} to this 20-bp region could not be demonstrated. It was found that E2 induction could be suppressed by the mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor, PD98059, and the epidermal growth factor receptor tyrosine kinase inhibitor, PD153035 hydrochloride. A significant induction of aromatase expression was also detected in ER-positive MCF-7 breast cancer cells after transfection with pCI-ER{alpha} and E2 treatment. Furthermore, after ER{alpha} transfection and E2 treatment, the aromatase activity in Her-2-overexpressing MCF-7 cells was drastically higher than that of the wild-type MCF-7 cells. In addition, aromatase induction in MCF-7 cells could also be suppressed by PD153035 hydrochloride. These results suggest that E2 up-regulates aromatase expression by a nongenomic action of ER{alpha} via cross-talk with growth factor-mediated pathways.




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
S. Catalano, I. Barone, C. Giordano, P. Rizza, H. Qi, G. Gu, R. Malivindi, D. Bonofiglio, and S. Ando
Rapid Estradiol/ER{alpha} Signaling Enhances Aromatase Enzymatic Activity in Breast Cancer Cells
Mol. Endocrinol., October 1, 2009; 23(10): 1634 - 1645.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Odawara, T. Iwasaki, J. Horiguchi, N. Rokutanda, K. Hirooka, W. Miyazaki, Y. Koibuchi, N. Shimokawa, Y. Iino, I. Takeyoshi, et al.
Activation of Aromatase Expression by Retinoic Acid Receptor-related Orphan Receptor (ROR) {alpha} in Breast Cancer Cells: IDENTIFICATION OF A NOVEL ROR RESPONSE ELEMENT
J. Biol. Chem., June 26, 2009; 284(26): 17711 - 17719.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. Kumar, A. Kamat, and C. R. Mendelson
Estrogen Receptor {alpha} (ER{alpha}) Mediates Stimulatory Effects of Estrogen on Aromatase (CYP19) Gene Expression in Human Placenta
Mol. Endocrinol., June 1, 2009; 23(6): 784 - 793.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
O. Bukulmez, D. B. Hardy, B. R. Carr, R. J. Auchus, T. Toloubeydokhti, R. A. Word, and C. R. Mendelson
Androstenedione Up-Regulation of Endometrial Aromatase Expression via Local Conversion to Estrogen: Potential Relevance to the Pathogenesis of Endometriosis
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3471 - 3477.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. F. Macedo, G. J. Sabnis, O. G. Goloubeva, and A. Brodie
Combination of Anastrozole with Fulvestrant in the Intratumoral Aromatase Xenograft Model
Cancer Res., May 1, 2008; 68(9): 3516 - 3522.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
H. K. Choi, S. H. Roh, H. G. Kim, E. H. Han, H. G. Jeong, and K. W. Kang
Enhanced expression of aromatase in p53-inactivated mammary epithelial cells
Endocr. Relat. Cancer, March 1, 2008; 15(1): 139 - 147.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Mah, D. B. Seligson, A. Li, D. C. Marquez, I. I. Wistuba, Y. Elshimali, M. C. Fishbein, D. Chia, R. J. Pietras, and L. Goodglick
Aromatase Expression Predicts Survival in Women with Early-Stage Non Small Cell Lung Cancer
Cancer Res., November 1, 2007; 67(21): 10484 - 10490.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. J. Pietras and D. C. Marquez-Garban
Membrane-Associated Estrogen Receptor Signaling Pathways in Human Cancers
Clin. Cancer Res., August 15, 2007; 13(16): 4672 - 4676.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
M. R. Sartippour, R. Pietras, D. C. Marquez-Garban, H.-W. Chen, D. Heber, S. M. Henning, G. Sartippour, L. Zhang, M. Lu, O. Weinberg, et al.
The combination of green tea and tamoxifen is effective against breast cancer
Carcinogenesis, December 1, 2006; 27(12): 2424 - 2433.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
R. J. Pietras
Biologic Basis of Sequential and Combination Therapies for Hormone-Responsive Breast Cancer
Oncologist, July 1, 2006; 11(7): 704 - 717.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Kijima, S. Phung, G. Hur, S.-L. Kwok, and S. Chen
Grape Seed Extract Is an Aromatase Inhibitor and a Suppressor of Aromatase Expression
Cancer Res., June 1, 2006; 66(11): 5960 - 5967.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Watanabe, Y. Kinoshita, K. Hosokawa, T. Mori, T. Yamaguchi, and H. Honjo
Function of Estrogen-Related Receptor {alpha} in Human Endometrial Cancer
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1573 - 1577.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
O. K. Weinberg, D. C. Marquez-Garban, M. C. Fishbein, L. Goodglick, H. J. Garban, S. M. Dubinett, and R. J. Pietras
Aromatase Inhibitors in Human Lung Cancer Therapy
Cancer Res., December 15, 2005; 65(24): 11287 - 11291.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
T. Suzuki, Y. Miki, Y. Nakamura, T. Moriya, K. Ito, N. Ohuchi, and H. Sasano
Sex steroid-producing enzymes in human breast cancer
Endocr. Relat. Cancer, December 1, 2005; 12(4): 701 - 720.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
S. C E Schuit, F. H de Jong, L. Stolk, W N. H Koek, J. B J van Meurs, M. W C J Schoofs, M C. Zillikens, A. Hofman, J. P T M van Leeuwen, H. A P Pols, et al.
Estrogen receptor alpha gene polymorphisms are associated with estradiol levels in postmenopausal women
Eur. J. Endocrinol., August 1, 2005; 153(2): 327 - 334.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. S. Diaz-Cruz, C. L. Shapiro, and R. W. Brueggemeier
Cyclooxygenase Inhibitors Suppress Aromatase Expression and Activity in Breast Cancer Cells
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2563 - 2570.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
J. S Lewis, T J Thomas, R. G Pestell, C. Albanese, M. A Gallo, and T. Thomas
Differential effects of 16{alpha}-hydroxyestrone and 2-methoxyestradiol on cyclin D1 involving the transcription factor ATF-2 in MCF-7 breast cancer cells
J. Mol. Endocrinol., February 1, 2005; 34(1): 91 - 105.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Chen, M. Cho, K. Karlsberg, D. Zhou, and Y.-C. Yuan
Biochemical and Biological Characterization of a Novel Anti-aromatase Coumarin Derivative
J. Biol. Chem., November 12, 2004; 279(46): 48071 - 48078.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. T. Akingbemi, C. M. Sottas, A. I. Koulova, G. R. Klinefelter, and M. P. Hardy
Inhibition of Testicular Steroidogenesis by the Xenoestrogen Bisphenol A Is Associated with Reduced Pituitary Luteinizing Hormone Secretion and Decreased Steroidogenic Enzyme Gene Expression in Rat Leydig Cells
Endocrinology, February 1, 2004; 145(2): 592 - 603.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Chauhan, S. Kunz, K. Davis, J. Roberts, G. Martin, M. C. Demetriou, T. C. Sroka, A. E. Cress, and R. L. Miesfeld
Androgen Control of Cell Proliferation and Cytoskeletal Reorganization in Human Fibrosarcoma Cells: ROLE OF RhoB SIGNALING
J. Biol. Chem., January 9, 2004; 279(2): 937 - 944.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.